When we compare life sciences and healthcare to other industries, the strategy in the former is much more fragmented. The pricing practices are also relatively unbalanced while the product cycle is quite long as well.
Enosi Life Sciences announced that it has appointed Dr. James Woody as its Executive Chairman. Having immense leadership skills, Dr. James holds over 25 years of experience in the pharmaceutical, venture capital, and biotech sectors. He also possesses medical expertise in antibody therapeutics and oncology.
The advent of coronavirus has threatened almost every job industry operating in the U.S. This has further affected the job market worldwide while creating a sense of fear among employees. Fortunately, the life sciences industry seems to be immune to the pandemic woes. The global deals within this sector accounted for $467 billion from 2013 to 2020.
On Wednesday, June 9, Natura & Co (NTCO3.SA), the parent company of Avon, announced that a “cyber incident” partially hit Avon operations the previous...